MAP Microba Life Sciences Ltd
- 0.170
- +0.010+6.25%
Microba Life Sciences Ltd News
Microba Life Sciences Ltd: Microba receives $6 million R&D Tax Incentive Refund
Microba Life Sciences Ltd: Annual Report to Shareholders
Microba Life Sciences Ltd: Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar
Clinical Microbiomics A/S Announces New Deal With Microba Life Sciences Ltd's and Prepares to Launch New Company Brand in November 2024
Analysts Expect Breakeven For Microba Life Sciences Limited (ASX:MAP) Before Long
Microba Life Sciences Agrees to Transfer Research Services Business to Clinical Microbiomics
Microba Life Sciences Ltd: 2024 Annual Report & Appendix 4E
Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%
Microba's Revenue Climbs 297% in Fiscal Q3
Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5%
Microba's Domestic Revenues to Get Boost From Sonic Partnership -- Market Talk
Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data
Microba Life Sciences Rise 9% Following Launch of MetaPanel Test With Sonic Healthcare
Miroba Life Sciences Price Target Cut 20% to A$0.35/Share by Bell Potter
Microbia Life Sciences Offers Compelling Long-Term Opportunity -- Market Talk
Microba Life Sciences Started With A$0.35/Share Target Price by Morgans>MAP.AU
Microba Life Sciences Validates Safety, Tolerability of Inflammatory Bowel Disease Therapy in Phase One Trial
Microba Life Sciences Completes Acquisition of UK Microbiome Testing Company; Shares Slide 5%
Microba Life Sciences Signs Research Agreement With IFF Subsidiary to Develop Allergy Treatments
Microba Life Sciences' Domestica, International Personal Testing Revenue Rises in Fiscal Q1
Analysis
Price Target
No Data
No Data